Hepatitis C treatment: recommendations 2016

Hepatitis C treatment: recommendations 2016

The ITPCru team and SEVT Ltd. have developed a chart “Hepatitis C treatment: recommendations 2016” which includes the recent recommendations for interferon-free treatment of HCV-monoinfected (EASL 2016) and HCV/HIV coinfected patients (EACS 2016). The chart also contains updated tables with all approved direct-acting antiviral drugs, as well as information about drug-drug interactions (HCV/HIV drugs).

The material can be downloaded from the following link:

By |2017-06-06T14:36:46+00:0019.09.2016|News, Материалы|1 Comment

One Comment

  1. elizabeth 13/03/2018 at 12:19 - Reply

    If you have significant liver dysunction as a result of the disease maybe your surgeon was reluctant to consider you as an implant candiate. Second opinion?

Leave A Comment